Literature DB >> 2546854

Suggestive evidence for inhibitory action of amiodarone on Na+, K+-pump activity in guinea pig heart.

M Aomine1.   

Abstract

1. Effects of amiodarone, a powerful antiarrhythmic agent, on Na+, K+-pump activity were examined on ventricular papillary muscle of guinea pig, by means of conventional microelectrode technique. 2. The activity of Na+, K+-pump was measured by two methods. One of them was to measure the amplitudes of depolarization observed during overdrive stimulation (3.3 Hz) and of hyperpolarization observed after the overdrive stimulation (post-overdrive hyperpolarization), and the other, to measure the hyperpolarization observed following introduction of 10 mM K+, after exposure to K+ free solution for a certain duration. 3. Amiodarone significantly decreased the amplitude of depolarization during overdrive stimulation and the amplitude of post-overdrive hyperpolarization. 4. In the latter method, the deactivation process of hyperpolarization recorded by the introduction of 10 mM K+ following K+ depletion slowed down by amiodarone. 5. These findings suggest that amiodarone may inhibit, at least in part, the Na+, K+-pump activity in the ventricular muscle of guinea pig.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546854     DOI: 10.1016/0306-3623(89)90201-2

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  3 in total

1.  Na+-K+ pump inhibition caused by chronic amiodarone in guinea pig myocardium.

Authors:  T Maruyama; N Ueda; Y Kaji; S Kanaya; T Fujino; Y Niho
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Influence of lorcainide on microsomal Na+, K(+)-ATPase in guinea-pig isolated heart preparations.

Authors:  A A Almotrefi; N Dzimiri
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

3.  Variations in potassium concentration modify the inhibitory effect of lorcainide on myocardial Na(+)-K(+)-ATPase activity.

Authors:  A A Almotrefi; N Dzimiri
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.